JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.
作者信息
Takase Bonpei, Ikeda Takanori, Shimizu Wataru, Abe Haruhiko, Aiba Takeshi, Chinushi Masaomi, Koba Shinji, Kusano Kengo, Niwano Shinichi, Takahashi Naohiko, Takatsuki Seiji, Tanno Kaoru, Watanabe Eiichi, Yoshioka Koichiro, Amino Mari, Fujino Tadashi, Iwasaki Yu-Ki, Kohno Ritsuko, Kinoshita Toshio, Kurita Yasuo, Masaki Nobuyuki, Murata Hiroshige, Shinohara Tetsuji, Yada Hirotaka, Yodogawa Kenji, Kimura Takeshi, Kurita Takashi, Nogami Akihiko, Sumitomo Naokata
机构信息
Division of Cardiology Iruma Heart Hospital.
Department of Cardiovascular Medicine Toho University Faculty of Medicine.
出版信息
J Arrhythm. 2024 Jun 12;40(4):655-752. doi: 10.1002/joa3.13052. eCollection 2024 Aug.
Abstract
摘要
相似文献
1
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.《日本循环学会/日本心律学会2022年心律失常诊断与风险评估指南》
J Arrhythm. 2024 Jun 12;40(4):655-752. doi: 10.1002/joa3.13052. eCollection 2024 Aug.
2
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.《日本循环学会/日本心律学会2022年心律失常诊断与风险评估指南》
Circ J. 2024 Aug 23;88(9):1509-1595. doi: 10.1253/circj.CJ-22-0827. Epub 2023 Sep 11.
3
CORRIGENDUM: JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias.勘误：《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
Circ J. 2021;85(9):1692-1700. doi: 10.1253/circj.CJ-66-0196.
4
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2020年心律失常药物治疗指南》
Circ J. 2022 Oct 25;86(11):1790-1924. doi: 10.1253/circj.CJ-20-1212. Epub 2022 Mar 11.
5
JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias.《日本循环学会/日本心律学会2021年心律失常非药物治疗指南重点更新》
J Arrhythm. 2022 Jan 7;38(1):1-30. doi: 10.1002/joa3.12649. eCollection 2022 Feb.
6
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2020年心律失常药物治疗指南》
J Arrhythm. 2022 Oct 25;38(6):833-973. doi: 10.1002/joa3.12714. eCollection 2022 Dec.
7
JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias.《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
J Arrhythm. 2021 Jun 2;37(4):709-870. doi: 10.1002/joa3.12491. eCollection 2021 Aug.
8
JCS/JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2021年心律失常非药物治疗指南重点更新》
Circ J. 2022 Jan 25;86(2):337-363. doi: 10.1253/circj.CJ-21-0162. Epub 2022 Jan 6.
9
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
Circ J. 2021 Jun 25;85(7):1104-1244. doi: 10.1253/circj.CJ-20-0637. Epub 2021 Jun 1.
10
JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk.日本循环学会/日本心律学会指南：不推荐利伐沙班用于非瓣膜性心房颤动且出血风险高的患者。
Circ J. 2022 Jun 24;86(7):1204. doi: 10.1253/circj.CJ-22-0146. Epub 2022 May 27.
引用本文的文献
1
The Effects of Endurance Training and High-Intensity Resistance Training on Pulse Wave Velocity and QT Dispersion.耐力训练和高强度抗阻训练对脉搏波速度和QT离散度的影响
Healthcare (Basel). 2025 Jan 15;13(2):161. doi: 10.3390/healthcare13020161.
2
Alleviating the Effects of Short QT Syndrome Type 3 by Allele-Specific Suppression of the Mutant Allele.通过对突变等位基因进行等位基因特异性抑制来减轻3型短QT综合征的影响。
Int J Mol Sci. 2024 Dec 12;25(24):13351. doi: 10.3390/ijms252413351.
本文引用的文献
1
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.《日本循环学会/日本心律学会2022年心律失常诊断与风险评估指南》
Circ J. 2024 Aug 23;88(9):1509-1595. doi: 10.1253/circj.CJ-22-0827. Epub 2023 Sep 11.
2
Mobile Health for Arrhythmia Diagnosis and Management.移动医疗在心律失常诊断与管理中的应用。
J Gen Intern Med. 2022 Jan;37(1):188-197. doi: 10.1007/s11606-021-07007-w. Epub 2021 Jul 19.
3
Arrhythmogenic left ventricular cardiomyopathy.致心律失常性左室心肌病
Heart. 2022 May;108(9):733-743. doi: 10.1136/heartjnl-2020-316944. Epub 2021 Jul 13.
4
Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial.人工智能心电图识别低射血分数患者的效果：一项实用、随机临床试验。
Nat Med. 2021 May;27(5):815-819. doi: 10.1038/s41591-021-01335-4. Epub 2021 May 6.
5
Using smart speakers to contactlessly monitor heart rhythms.使用智能音箱进行非接触式心率监测。
Commun Biol. 2021 Mar 9;4(1):319. doi: 10.1038/s42003-021-01824-9.
6
Electrocardiogram screening for aortic valve stenosis using artificial intelligence.人工智能在主动脉瓣狭窄中的心电图筛查。
Eur Heart J. 2021 Aug 7;42(30):2885-2896. doi: 10.1093/eurheartj/ehab153.
7
Tilt testing remains a valuable asset.倾斜试验仍然是一项有价值的资产。
Eur Heart J. 2021 May 1;42(17):1654-1660. doi: 10.1093/eurheartj/ehab084.
8
Improving electrocardiogram-based detection of rare genetic heart disease using transfer learning: An application to phospholamban p.Arg14del mutation carriers.利用迁移学习提高基于心电图的罕见遗传性心脏病检测：在磷酸化酶肌球蛋白结合蛋白 p.Arg14del 突变携带者中的应用。
Comput Biol Med. 2021 Apr;131:104262. doi: 10.1016/j.compbiomed.2021.104262. Epub 2021 Feb 11.
9
Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead ECG and Help Identify Those at Risk of Atrial Fibrillation-Related Stroke.深度神经网络可通过 12 导联心电图预测新发心房颤动，并有助于识别心房颤动相关卒中风险。
Circulation. 2021 Mar 30;143(13):1287-1298. doi: 10.1161/CIRCULATIONAHA.120.047829. Epub 2021 Feb 16.
10
Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram.基于体表 12 导联心电图评估心电图隐匿性长 QT 综合征患者中人工智能和深度神经网络的应用。
JAMA Cardiol. 2021 May 1;6(5):532-538. doi: 10.1001/jamacardio.2020.7422.
Zotero 插件